Last reviewed · How we verify
NCT04546516: PMCF_HYAcorp
Safety and Efficacy of the HA-based Dermal Fillers HYAcorp Lips and Face
trial testing HYAcorp Lips and HYAcorp Face in Dermal Filler in 167 participants. Completed in 31 December 2022.
22 January 2022
Quick facts
| Lead sponsor | BioSCIENCE GmbH |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 167 |
| Start date | 8 September 2020 |
| Primary completion | 22 January 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 2 locations across Germany |
Drugs / interventions tested
- HYAcorp Lips and HYAcorp Face
Conditions studied
- Dermal Filler — all drugs for Dermal Filler →
Sponsor
BioSCIENCE GmbH — full company profile →
Who can join
18 and older, any sex, with Dermal Filler. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Purpose of this study is the demonstration of safety and efficacy of the dermal fillers HYAcorp Lips and HYAcorp Face for restoration of the facial volume and contour.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04546516
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other BioSCIENCE GmbH trials
Trials by the same sponsor.
- NCT04546152 — Safety and Efficacy of the HA-based Dermal Fillers HYAPROF® SOFT and HYAPROF® BALANCE · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04546516 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by BioSCIENCE GmbH
- Last refreshed: 17 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04546516.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing